Related Experiment Video
Updated: Aug 23, 2026

Assay Development for High Content Quantification of Sod1 Mutant Protein Aggregate Formation in Living Cells
Published on: October 4, 2017
Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria
Jian Liu1, Concepción Lillo, P Andreas Jonsson
1Ludwig Institute for Cancer Research, Department of Neurosciences, Medicine, and Cellular and Molecular Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA.
Abstract:
One cause of amyotrophic lateral sclerosis (ALS) is mutation in ubiquitously expressed copper/zinc superoxide dismutase (SOD1), but the mechanism of toxicity to motor neurons is unknown. Multiple disease-causing mutants, but not wild-type SOD1, are now demonstrated to be recruited to mitochondria, but only in affected tissues. This is independent of the copper chaperone for SOD1 and dismutase activity. Highly preferential association with spinal cord mitochondria is seen in human ALS for a mutant SOD1 that accumulates only to trace cytoplasmic levels. Despite variable proportions that are successfully imported, nearly constant amounts of SOD1 mutants and covalently damaged adducts of them accumulate as apparent import intermediates and/or are tightly aggregated or crosslinked onto integral membrane components on the cytoplasmic face of those mitochondria. These findings implicate damage from action of spinal cord-specific factors that recruit mutant SOD1 to spinal mitochondria as the basis for their selective toxicity in ALS.
Insights
Mutant copper/zinc superoxide dismutase (SOD1) proteins, a cause of amyotrophic lateral sclerosis (ALS), are recruited to spinal cord mitochondria, leading to motor neuron toxicity. This mitochondrial recruitment is linked to disease-specific factors.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease linked to mutations in the copper/zinc superoxide dismutase (SOD1) gene.
- The precise mechanism by which mutant SOD1 causes motor neuron degeneration remains largely unknown.
- SOD1 is ubiquitously expressed, but its toxicity in ALS appears to be restricted to specific tissues, particularly the spinal cord.
Purpose of the Study:
- To investigate the cellular localization and potential mechanisms of toxicity for mutant SOD1 in the context of ALS.
- To determine if mutant SOD1 is targeted to specific cellular organelles, such as mitochondria, in affected tissues.
- To explore the role of mitochondrial recruitment and subsequent damage in the selective motor neuron pathology observed in ALS.
Main Methods:
- Immunohistochemistry and biochemical assays were used to detect and quantify SOD1 protein localization in spinal cord tissues from ALS patients and controls.
- Mitochondria were isolated from affected tissues to analyze SOD1 association and potential import intermediates.
- The study examined the relationship between cytoplasmic SOD1 levels, mitochondrial import, and the formation of aggregated or crosslinked SOD1 adducts.
Main Results:
- Disease-causing SOD1 mutants, but not wild-type SOD1, were found to be recruited to mitochondria, specifically in affected tissues like the spinal cord.
- This mitochondrial recruitment occurred independently of the copper chaperone for SOD1 and its dismutase activity.
- Mutant SOD1, even at trace cytoplasmic levels, showed preferential association with spinal cord mitochondria, accumulating as import intermediates or aggregated adducts on the mitochondrial surface.
Conclusions:
- The selective toxicity of mutant SOD1 in ALS is implicated by its recruitment to spinal cord mitochondria.
- Spinal cord-specific factors likely play a crucial role in targeting mutant SOD1 to mitochondria.
- Damage resulting from the interaction of mutant SOD1 with spinal mitochondria is proposed as the basis for selective motor neuron toxicity in ALS.
Related Concept Videos
ATP Synthase: Mechanism
Lysosomal Hydrolases
Parkinson Disease ll: Pathophysiology

